ILiAD Biotechnologies | RoundOS

Weekly digest by email

Loading companies…

ILiAD Biotechnologies | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Feb 10, 2026	Series B	$115M	AI Life Sciences — Role not disclosedBNP Paribas Asset Management Alts — Role not disclosedJanus Henderson Investors — Role not disclosedRA Capital Management — Role not disclosed

Investors

AI Life SciencesSeries B BNP Paribas Asset Management AltsSeries B Janus Henderson InvestorsSeries B RA Capital ManagementSeries B

Coverage

Feb 10, 2026ILiAD Biotechnologies · Series B

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

TransfyrPhysical AI platform capturing real-world lab science into machine-readable data$25M · Seed

Sources

iliadbio.com ↗